guaifenesin: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
guaifenesin: clinical details
Prescribing considerations
- Confirm a productive cough and assess persistent, recurrent or unexplained cough before symptomatic treatment.
- Check for duplicate active ingredients in other cough and cold products.
- Apply the age restriction for the specific product; selected adult products exclude children under 12, while the selected children's product is for ages 6 to 12.
- Review relevant excipients, including sucrose, sorbitol, glycerol, ethanol, propylene glycol, sodium benzoate, benzyl alcohol and colouring agents.
Contraindications and cautions
- Hypersensitivity to guaifenesin or a formulation component
- Age below the licensed limit of the chosen product
- Porphyria for Covonia Chesty Cough Sugar Free Syrup
- Hereditary fructose intolerance or relevant sugar-malabsorption disorders where specified by the formulation
Monitoring
- Routine laboratory monitoring is not usually required for short-term symptomatic use.
- Review cough that persists, recurs or worsens, or is accompanied by fever, rash, persistent headache or breathlessness.
- Monitor for gastrointestinal intolerance and hypersensitivity.
- Warn laboratories about recent use before urinary 5-HIAA or VMA testing.
Clinical pharmacology
Guaifenesin is an expectorant that increases respiratory secretions and facilitates mucus removal through ciliary activity and coughing. It is absorbed from the gastrointestinal tract, metabolised and excreted in urine.
Formulation and product differences
- Covonia is a sugar-free syrup containing sorbitol, propylene glycol and Ponceau 4R; it requires shaking and is contraindicated in porphyria.
- Boots Mucus Cough Relief contains sucrose and glycerol.
- Robitussin contains ethanol, sorbitol, maltitol, propylene glycol and sodium benzoate.
- Benylin Children's Chesty Coughs is a paediatric syrup containing sorbitol, sodium salts and benzyl alcohol, with different age licensing from adult products.
guaifenesin preparations and strengths
Oral solution
Route: Oral
Strengths: 100 mg/5 mL
Syrup
Route: Oral
Strengths: 100 mg/5 mL
guaifenesin interactions
Clinically important interactions are uncommon, but duplication, excipients and laboratory-test interference matter.
Other cough and cold products
Using more than one product can duplicate guaifenesin or other active ingredients and increase adverse effects.
Cough suppressants
The selected children's product advises against combining an expectorant with a cough suppressant.
Medicines containing alcohol or propylene glycol
Combining these with an alcohol-containing guaifenesin formulation may increase excipient exposure and adverse effects.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.